1. Home
  2. NKTR vs ATHM Comparison

NKTR vs ATHM Comparison

Compare NKTR & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$72.79

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

ATHM

Autohome Inc.

HOLD

Current Price

$21.21

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
ATHM
Founded
1990
2008
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
NKTR
ATHM
Price
$72.79
$21.21
Analyst Decision
Strong Buy
Hold
Analyst Count
7
1
Target Price
$146.67
$28.00
AVG Volume (30 Days)
481.5K
706.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
9.83%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$307,711,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.77
P/E Ratio
N/A
$12.13
Revenue Growth
86.00
N/A
52 Week Low
$33.40
$15.57
52 Week High
$109.00
$29.92

Technical Indicators

Market Signals
Indicator
NKTR
ATHM
Relative Strength Index (RSI) 49.04 43.15
Support Level $70.24 $20.75
Resistance Level $76.49 $22.47
Average True Range (ATR) 2.86 0.73
MACD -0.17 -0.14
Stochastic Oscillator 36.36 17.22

Price Performance

Historical Comparison
NKTR
ATHM

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.

Share on Social Networks: